Optimum expression of adult lung function based on all-cause mortality: Results from the Reykjavik study

被引:34
作者
Chinn, S.
Gislason, T.
Aspelund, T.
Gudnason, V.
机构
[1] Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England
[2] Landspitali Univ Hosp, Dept Allergy Resp Med & Sleep, Reykjavik, Iceland
[3] Iceland Heart Assoc, Reykjavik, Iceland
关键词
mortality; proportional hazards models; respiratory function tests; smoking; survival rates;
D O I
10.1016/j.rmed.2006.06.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A variety of reference curves are used to derive predicted values for adult lung function, even within ethnically similar populations. Alternatives to percentage predicted value are sometimes used to allow for height in research. Strength of association with total mortality can be used to choose the optimal expression, between forced expiratory volume in 1 s (FEV1) divided by height(2), FEV1/height(3), FEV1% predicted and difference from predicted. Data from the Reykjavik Study cohort, 1976-2002, included 5544 men and 8062 women randomly selected from the population. Total mortality was analysed by Cox proportional hazards regression in relation to each height-adjusted measure, allowing for age group, period of recruitment and body mass index, and smoking before or at baseline. FEV1/height(2) and FEV1/height(3) had stronger associations with mortality than FEV1% predicted and difference from predicted in men and in women. There were similar findings for forced vital capacity (FVC) in non-smokers and in women. FEV1/height(2) was slightly better predictive than FEV1/height(3) in men, but distributions of FEV1/height(3) in men and women were closer than those of FEV1/height(2). Clinical practise and epidemiological research would benefit from agreement on how to adjust lung function for height. Replication of these analyses in other cohort studies would inform the choice between FEV1/height(2) and FEV1/height(3). (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:601 / 609
页数:9
相关论文
共 27 条
[21]   References values for forced spirometry [J].
Roca, J ;
Burgos, F ;
Sunyer, J ;
Saez, M ;
Chinn, S ;
Anto, JM ;
Rodriguez-Roisin, R ;
Quanjer, PH ;
Nowak, D ;
Burney, P .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (06) :1354-1362
[22]   The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population [J].
Schünemann, HJ ;
Grant, BJB ;
Freudenheim, JL ;
Muti, P ;
Browne, RW ;
Drake, JA ;
Klocke, RA ;
Trevisan, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (05) :1246-1255
[23]   Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality [J].
Smith, GD ;
Hart, C ;
Upton, M ;
Hole, D ;
Gillis, C ;
Watt, G ;
Hawthorne, V .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2000, 54 (02) :97-103
[24]   Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley study [J].
Smith, GD ;
Hart, C ;
Watt, G ;
Hole, D ;
Hawthorne, V .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1998, 52 (06) :399-405
[25]   MORTALITY ASSOCIATED WITH RESPIRATORY-FUNCTION AND SYMPTOMS IN ADVANCED AGE - THE FRAMINGHAM-STUDY [J].
SORLIE, PD ;
KANNEL, WB ;
OCONNOR, G .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :379-384
[26]   Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males [J].
Stavem, K ;
Aaser, E ;
Sandvik, L ;
Bjornholt, JV ;
Erikssen, G ;
Thaulow, E ;
Erikssen, J .
EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (04) :618-625
[27]   Level of FEV1 as a predictor of all-cause and cardiovascular mortality:: an effect beyond smoking and physical fitness? [J].
Sunyer, J ;
Ulrik, CS .
EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (04) :587-588